President and CEO of French drug maker Paul Hudson said on Wednesday that doses of vaccine produced in the United States may go to American patients first, given that the country had supported the research.
Sanofi, which had already pointed out this possibility in recent weeks and called for reinforced European coordination in the search for a vaccine, has since specified that it would be made available to all, following a backlash in France in particular .
“It would of course be unacceptable for us to have privileged access to such and such a country on the pretext of pecuniary motive, especially in the current context”, explained to Sud Radio Agnès Pannier-Runacher, Minister for the French economy . (Report by Henri-Pierre Andre and Jean-Stephane Brosse, Writing by Sarah White and Benoit Van Overstraeten: Edition by Nick Macfie)
Our standards:Principles of the Thomson Reuters Trust.